Want to join the conversation?
For 2016, $CMTL's revenues totaled $411MM and adjusted EBITDA was $48.1MM. The company's GAAP diluted EPS for the full year 2016 was a loss of $0.46 per share, given the $21.3MM of merger cost and integration expenses association with the TCS acquisition that was recorded earlier in the year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?